Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy
U.S. STOCKS ON THE MOVE-Waldencast, Danaher, Asset Entities
U.S. STOCKS ON THE MOVE-Nike, US chipmakers, Greenwich LifeSciences
H.C. Wainwright downgrades Tourmaline Bio to 'neutral' after $1.4 billion buyout deal
U.S. RESEARCH ROUNDUP-Citigroup, Oracle, Synopsys
U.S. STOCKS ON THE MOVE-Anavex Life Sciences, Oil companies, Yum! Brands
U.S. STOCKS ON THE MOVE-Anavex Life Sciences, oil companies, Yum Brands
Tourmaline soars after Novartis to acquire co for $1.4 billion
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Wix.com, NextDecade
U.S. STOCKS ON THE MOVE-CleanCore Solutions, Wolfspeed, UnitedHealth
Brief: Tourmaline Bio To Receive Termination Fee Of $68.5 Million If Merger Terminated - SEC Filing
Tourmaline soars after Novartis to acquire co for $1.4 billion
Novartis to acquire Tourmaline Bio for $1.4 billion (updated)
Swiss stocks - Factors to watch on September 9
Novartis to acquire Tourmaline Bio in deal valuing it at $1.4 billion